Status:

WITHDRAWN

The Efficacy of CALPXT96™in Improving Sleep Quality in Patients With Chronic Non-cancer Pain

Lead Sponsor:

9305-9954 Quebec Inc

Collaborating Sponsors:

McMaster University

Conditions:

Chronic Pain

Insomnia

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

California Poppy has been traditionally used in Herbal Medicine as an analgesic, mild sedative and/or sleep aid. However there are no human clinical trial data to support its use. Sleep disturbances a...

Detailed Description

Study Design: This will be an 'n of 1' model, with the patient acting as their own control. To identify any possible negative 'wash out' effect after cessation of the active medication (that could ne...

Eligibility Criteria

Inclusion

  • Age \> 17 and \< 75
  • Chronic non-cancer pain (CNCP) associated with a complaint of poor sleep. Validated tool the Pittsburgh Sleep Quality Index (PSQI) for sleep dysfunction and using a suitable cut points (PSQI \>/=5) to ensure greater homogeneity of the sample and the recruitment of only those with significant pain related sleep disturbance.
  • Stable pain management therapy for 1 month prior to entry into the study
  • Having a confirmed diagnosis of CNCP for greater than 1 year
  • Written informed consent obtained.
  • Subject agreed to follow the protocol.

Exclusion

  • Taking a hypnotic medication at time of enrollment. Patients may be enrolled if they are willing to cease any current hypnotic for at least 2 weeks prior to commencing the study
  • Current alcohol abuse or other addiction
  • Sleep apnea disorder
  • Inability to understand and comply with the instructions of the study
  • Previous enrollment in the study
  • Renal and/or liver insufficiency
  • Patients less than age 18
  • Pregnancy or lactation
  • Current (\</=one year) DSM-IV Axis I diagnosis of major depressive disorder, dysthymia, generalized anxiety disorder and DSM-IV diagnosis of mania, bipolar disorder, or psychosis determined either by patient history

Key Trial Info

Start Date :

December 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2016

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT02232256

Start Date

December 1 2015

End Date

December 1 2016

Last Update

April 26 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CPM - Centres for Pain Managemen

Mississauga, Ontario, Canada, L5N 3E7

The Efficacy of CALPXT96™in Improving Sleep Quality in Patients With Chronic Non-cancer Pain | DecenTrialz